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http:WHAT THIS PAPER ADDS
This is the largest series presented to date of use of self-expanding stents (SES) in the chimney graft (CG)
technique for endovascular repair (EVAR) of juxtarenal aortic aneurysms (JRAA). The so-called Open Chimney
(OCh) EVAR has the advantages of reducing complexity, manufacturing time, and costs of fenestrated EVAR in
selected JRAA. Moreover, compared with covered stents, use of SES in the GG technique allows a size reduction
in the sheath introducer from the left brachial access, possibly decreasing cerebrovascular complications and
also permits improved blood ﬂow to the stented renal artery, possibly giving an advantage in the target vessel
long-term patency.Objectives: A straightforward original Chimney Graft (CG) protocol has been developed at our institution in
selected cases of juxtarenal aortic aneurysm (JRAA). The aim of this study was to present our clinical experience
of consecutive series with use of uncovered self-expanding stent (SES) as “Open Chimney” (OCh) in the
endovascular repair (EVAR) of JRAA.
Methods: A standard endograft with suprarenal ﬁxation struts is delivered with its proximal covered edge just
below the highest RA in JRAA presenting the ostium of the two renal arteries at a different aortic level and the
distance between the highest renal artery and the beginning of the aneurysm (improved landing zone) 10 mm.
The low-lying renal artery is maintained patent by the OCh graft (standard SES) delivered from left brachial access
(6 Fr). All clinical, anatomical, and operative data were prospectively collected and retrieved for the study
analysis.
Results: From July 2010 to November 2012, OCh EVAR was offered to 22 consecutive patients considered unﬁt
for JRAA open repair. All procedures were technically successful with aneurysm exclusion and patent OCh graft.
One small perioperative type Ia endoleak spontaneously disappeared at the 3-month CT control. One patient
died because of acute decompensated heart failure. One patient presented a left hemispheric stroke. The median
follow-up of 18 months (range 7e35) showed aneurysm exclusion in all patients without type I and III endoleaks,
SES stenosis, and/or renal impairment.
Conclusions: OCh-EVAR is a straightforward technique that can be employed in selected cases of JRAA, avoiding
the more complex and expensive fenestrated EVAR.
 2013 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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The lack of a suitable proximal neck is the most common
factor precluding standard endovascular repair (EVAR) in
abdominal aortic aneurysms (AAA). A proximal landing zone
(LZ) shorter than 10 mm is a contraindication for all endo-
vascular grafts currently available “off-the-shelf”. Distinctresponding author. S. Lepidi, Vascular Surgery Unit, Pellegrin Hos-
niversity of Bordeaux, Place Amelie Raba e Léon, 33076 Bordeaux,
.
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//dx.doi.org/10.1016/j.ejvs.2013.10.022from infrarenal AAAs, juxtarenal aortic aneurysms (JRAAs)
carry greater morbidity and mortality rates with open sur-
gery.1,2 A minimally invasive approach should be advocated
in patients at high physiological risk.3
Technology is now available for fenestrated (F)-EVAR
devices to obtain an adequate sealing above the oriﬁces of
renal or mesenteric arteries.4,5 However, F-EVAR requires
extensive experience in standard EVAR, renal vessel cathe-
terisation as well as stent delivery and shaping, experience
which can only be obtained in referral centres specialising in
complex aortic treatment.
The need for “off-the-shelf” endovascular grafts and
simpliﬁcation of the suprarenal sealing zone technique has
Figure 1. Schematic drawing of the proximal landing zone evalu-
ation. D1: Infrarenal diameter 15 mm below the lowest RA; D2:
diameter of the improved proximal landing zone; L1: infrarenal
neck length, L2: diameter of the lowest RA; L3: distance between
bottom of the highest to top of the lowest RA; LZ: landing
zone ¼ L1 þ L2 þ L3.
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to the endovascular treatment of JRAA called the “snorkel”
or “chimney” graft (CG) technique. First described by
Greenberg et al.,6 the CG technique consists of the delivery
of parallel stents adjacent to the endograft main body to
maintain perfusion to renal and/or visceral arteries and gain
a suprarenal sealing zone using standard EVAR grafts.
An F-EVAR and subsequently a CG-EVAR programme have
been established for JRAA since 2006 in our department.
A straightforward chimney technique protocol has been
developed to treat patients with JRAA when the two main
renal arteries (RAs) arise from the aorta at different cross-
sectional levels (discrepant; the lower margin of the up-
per renal artery is above the upper margin of the lower
one) and the distance between the highest RA and the
beginning of the aneurysm (improved landing zone) is
10 mm. To obtain an adequate proximal LZ, a standard
endograft with suprarenal ﬁxation struts is delivered with
its proximal covered edge just below the highest RA,
whereas the low-lying renal artery is maintained patent by
an uncovered self-expanding stent (SES) called “Open
Chimney” (OCh).
The aim of the present study is to report preoperative
clinical and anatomical patient characteristics, operative
data as well as perioperative, and follow-up results of the
OCh technique.
MATERIALS AND METHODS
Patients and anatomical evaluation
From July 2010 to November 2012, OCh-EVAR was per-
formed for JRAA in consecutive patients with discrepant
RAs. The proximal LZ was relocated below the highest RA
(Fig. 1) and included the length of infrarenal neck (L1), the
diameter of lowest RA (L2) and the distance between RAs
(L3). The anatomical inclusion criteria were deﬁned as L1
between 1 and 9 mm, LZ 10 mm and a regular, parallel-
shaped LZ with a diameter 32 mm. Contraindication to
OCh-EVAR was a conical-shaped LZ with diameter increasing
downward >2 mm, as well as with presence of thrombus
and calciﬁcation.
All anatomical features were documented according to
recommended standards with the exception of the aortic
angle F, deﬁned as the most acute angle in the pathway
between the lowest renal artery and the aortic bifurcation.7
Having relocated the proximal neck above the lowest RA, F
was considered the most acute angle in the pathway be-
tween the highest RA and the aortic bifurcation.
Patients with JRAA and emergence of the two main RA at
the same cross-sectional level were evaluated for F- or CG-
EVAR using covered stents for both RAs.
Only high-risk patients with comorbidities prohibitive for
open surgery were considered candidates for OCh-EVAR.
These included patients with poorly compensated or
recurrent congestive heart failure, ejection fraction 35%,
severe aortic valve stenosis, myocardial infarction within 6
months, symptomatic or poorly controlled ectopy/
arrhythmia (chronic/recurrent), pulmonary dysfunction(forced expiratory volume in 1 second of 1 L) or requiring
oxygen replacement therapy, and those with a hostile
abdomen as a result of multiple prior abdominal surgeries.
Patients were preoperatively evaluated by attending phy-
sicians, hospital anesthesiologists, and cardiologists when
more accurate assessments were needed.
The study methodology and design were approved by the
local university hospital board and written informed con-
sent was obtained for all patients.
All patients underwent abdominal and thoracic CT scan
examination and DICOM images were analysed on a PC
workstation using Dx Care (Medasys, Gif-sur-Yvette, France)
software Ver. 6.3e14. Thoracic CT scan images were eval-
uated for arch and left subclavian anatomy owing to
chimney graft delivery.
All patients in this series underwent ﬁrst-time repair of
JRAA. No patients with ruptured or leaking JRAAs were
treated with OCh-EVAR. No devices were modiﬁed or
altered before implantation. Increased oversizing was not
planned for OCh-EVAR compared with standard EVAR.Procedural technique
All procedures were carried out by, or under the supervision
of, the same vascular team, in a hybrid surgical room with a
portable C-Arm Fluoroscope.
All patients underwent general anaesthesia. Through
small (3e5 cm) longitudinal incisions, both femoral and the
proximal left brachial arteries were surgically exposed.
Systemic heparin sodium (5,000 units by intravenous in-
jection) was given. Over a hydrophilic 0.035 guidewire, 9F
12 cm-long (Terumo Europe, Leuven, Belgium) sheaths were
inserted into both common femoral arteries and a 5F
12 cm-long sheath (Terumo) into the left brachial artery.
From the left brachial access, a hydrophilic 0.035 guide-
wire was positioned in the distal descending thoracic aorta,
the 5F sheath exchanged for a 6F, 65 cm-long sheath
(Destination, Terumo) and through it, the lowest renal ar-
tery was targeted. Using a hydrophilic guidewire, a 5F
vertebral catheter was inserted well into the lowest renal
artery and a wire exchange was made for a superstiff 0.035
Table 1. Patient demographics, perioperative and follow-up
outcomes.
Variable N ¼ 22
Age, years, median (range) 73 (63e88)
Preoperative comorbidities N (%)
Cardiac disease 17 (77)
Previous myocardial infarction 6 (27)
Chronic heart failure 3 (14)
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endograft main body was introduced from the selected
femoral access and placed in the infrarenal aorta. Only
endografts with suprarenal uncovered stents ﬁxation were
employed. An uncovered nitinol self-expanding stent (SES)
of appropriate length and diameter was placed into the
target vessel without releasing it. Under roadmap acquisi-
tion, the endograft was deployed with the proximal edge of
the ﬁrst covered stent just below the highest main RA,
without completely releasing the proximal uncovered stents
of the endograft. The previously positioned renal SES, was
then opened to allow RA perfusion. SES was delivered 2 to
3 cm into the RA with its proximal end opening at the
middle portion of the suprarenal uncovered endograft
stents, which were ﬁnally completely released. Catheter-
isation of the contralateral endograft leg was then
completed and iliac limbs delivered. The entire endograft
was dilated using a compliant balloon, without any need for
simultaneous SES ballooning. However, the guidewire was
always left inside the stented renal artery for possible
balloon dilatation after the ﬁnal angiographic control.
Completion angiography was performed to assess the cor-
rect endograft position, the absence of stent stenosis, RAs
perfusion, and presence of any type of endoleak.Previous interventions
CABG 3 (14)
PTCA  stent 6 (27)
Abdominal surgery 4 (18)
Ejection fraction 35% 4 (18)
Hypertension 18 (81)
Hyperlipidaemia 17 (77)
History of smoking 20 (90)
Active smoker 6 (27)
COPD 4 (18)
Diabetes mellitus 2 (9)
Renal insufﬁciency (creatinine 1.5 mg/dL) 4 (18)
Hostile abdomen 4 (18)
Peripheral arterial disease 8 (36)
Previous cerebrovascular event 2 (9)
Perioperative Median (range)
Fluoroscopy time, minutes 23 (15e55)
Contrast dose, mL 65 (45e120)
Operative time, minutes 105 (75e290)
Estimated blood loss, mL 55 (30e550)
Length of stay, days 6.5 (4e50)
Follow-up
Follow-up time, months 18 (7e35)
Creatinine, mg/dL
Baseline 1.04 (0.62e1.75)
Highest post-op 1.04 (0.71e4.5)
Latest follow-up 1.02 (0.72e2.8)
Estimated (MDRD formula) GFR, mL/min/1.73 m2
Baseline 68 (39e130)
Lowest post-op 73 (30e126)
Latest follow-up 72 (23e110)
Pre-op aneurysm size, mm 59 (45e100)
Sac regression at latest follow-up, mm 9 (0e18)
CABG ¼ coronary artery bypass grafting; COPD ¼ chronic
obstructive pulmonary disease; PTCA ¼ percutaneous
transluminal coronary angioplasty; GFR ¼ glomerular ﬁltration
rate.Postoperative management and data presentation
Double antiplatelet drugs (clopidogrel and aspirin) were
given for at least 1 month, followed by lifelong single an-
tiplatelet drug therapy.
Contrast CT scan control was performed before discharge,
between 3 and 6 months postoperatively, and yearly
thereafter. Non contrast-CT and Duplex scan were per-
formed in patients with renal insufﬁciency. Clinical follow-
up consisted of physical and laboratory examinations
including serum creatinine at 1 month, 6 months, and
yearly thereafter if no complications were observed. Addi-
tional clinical, laboratory, and Duplex-scan examinations
were performed for all patients at the end of the present
study for investigational purposes.
All clinical, anatomical, and operative data were prospec-
tively collected in an expressly designed database and
retrieved for the study analysis. Primary end points were
technical success (successfully completed procedure with
endograft patency, preservation of target vessels, and no
evidence of type I or III endoleak at post-procedural imaging),
30-daymortality andmorbidity. Follow-upwas focused on all-
cause mortality, branch vessel patency, renal impairment,
and secondary interventions. Because of the small number of
patients, no control groups were selected for the study and
data are presented in a descriptive analytic method. Cate-
goric data are described using absolute numbers and per-
centage of prevalence (%) in the study cohort, whereas
continuous variables are presented as median (range).
RESULTS
OCh-EVAR was offered to 22 consecutive patients (21 male)
considered to be at excessive risk for open repair for JRAA.Seventeen procedures were performed at the main study
centre and the remaining ﬁve were performed at other
European vascular surgery centres, where the same team
was tutoring for complex endovascular aortic procedures.
During the same period of time 84 patients with JRAA un-
derwent F- (62 patients) or CG-EVAR (22 patients) using 2
covered stents. Four patients underwent urgent CG-EVAR
for contained ruptured JRAAs.
Comorbidities typical of this high-risk cohort for AAA
patients are presented in Table 1.
Thirteen patients (59%) were American Society of Anes-
thesiologists class 3, ﬁve patients (23%) were class 4, and
were felt to be unsuitable candidates for major open sur-
gery by the in-hospital cardiologist and operative team.
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multiple previous intra-abdominal surgeries.
Anatomical aneurysm characteristics are reported in
Table 2. The median aneurysm size was 58.5 mm (45e100).
One patient was operated for a small (45 mm) rapidly
enlarging saccular aneurysm. All patients were asymptom-
atic with a recently discovered JRAA. The median L1
(infrarenal neck length) of 4.5 mm (1e9) and D1 (diameter
15 mm below the lowest RA) of 40.5 mm (35e65) were
prohibitive for standard EVAR. The improved landing zone
presented a median length (LZ) of 19 mm (11e26) and a
median diameter (D2) of 23 mm (18e32), enabling OCh-
EVAR. The median aortic angle F was 125 (75e160).
Endografts and SES employed are detailed for all patients
in Table 3 along with the perioperative and follow-up com-
plications. The endografts employed were 19 Zenith (Cook)
AAA (5 Flex, 12 Low-Proﬁle, 1 AUI and 1 Renu), 1 Endurant
(Medtronic Vascular, Santa Rosa, CA, USA) and 1 Powerlink
(Endologix, Inc, Irvine, CA, USA). All renal open chimney graft
were nitinol SES and included 13 Lifestent (Bard, Murray Hill,
NJ, USA), 3 Absolute Pro (Abbott, Santa Clara, CA, USA), 2
Astron (Biotronic, Bülach, Switzerland), 2 Epic Vascular
(Boston Scientiﬁc,Maple Grove,MN, USA), 1 Protégé Everﬂex
(EV3-Covidien, Plymouth, MN, USA), and 1 S.M.A.R.T. Control
(Cordis, J&JMedical,Miami, FL, USA). Stent diameters ranged
from 5 to 7 mm and lengths from 30 to 60 mm. The median
percentage of endograft oversizing was 15 (11e21). The left
RA was targeted in 17 patients. Balloon dilatation of SES was
never required after its delivery. Femorofemoral crossover
graft was accomplished in two patients undergoing aortou-
niliac EVAR for a narrow aortic carrefour.
All the procedures were technically successful with JRAA
exclusion and patent chimney graft, except for the occurrenceTable 2. Juxtarenal aortic aneurysm (JRAA) morphology.
Pt. Age AAA D1 D2
1 78 58 50 26
2 64 90 63 26
3 88 56 45 22
4 72 60 41 22
5 85 45 40 25
6 72 68 65 24
7 63 54 50 26
8 64 53 38 21
9 71 59 36 28
10 77 54 35 24
11 73 54 39 22
12 87 90 40 20
13 66 76 65 21
14 68 70 56 25
15 73 100 64 32
16 67 55 37 20
17 83 61 39 23
18 79 54 38 24
19 77 69 63 23
20 81 53 36 28
21 66 75 46 21
22 83 50 37 18
AAA ¼ maximal aneurysm diameter. LZ ¼ L1 þ L2 þ L3. Diameters aof one type Ia endoleak. Because of its small entity, it was
decided not to treat the endoleak immediately. The 3-month
CT control showed a complete regression of the endoleak.
Four type II endoleakswere also detected atﬁnal angiography,
one disappeared at the 6-month CT control. One accessory
renal artery was present in ﬁve patients and occluded in two
without renal function changes. Table 1 summarises periop-
erative outcomes as well as follow-up results regarding renal
function and aneurysm sac evolution. The median length of
the procedure was 105 minutes (75e290), blood loss 55 ml
(30e550) and hospital stay 6.5 days (4e50).
Two major perioperative complications were observed.
One patient died (4.5%) in the intensive care unit 4 hours
after the procedure because of acute decompensated heart
failure. The patient presented a history of recurrent
congestive heart failure with an ejection fraction <30%. The
patient had a complex procedure characterised by suc-
cessful aneurysm exclusion with right renal artery OCh, yet
immediately complicated by bilateral iliac leg thrombosis,
probably caused by an underlying undetected coagulopathy
and poor lower limb outﬂow. Several endograft thrombec-
tomies and associated distal iliac and femoral bilateral an-
gioplasties led to iliac leg patency with good distal outﬂow.
One patient presented an immediate post-procedural right
hemiplegia. The following CT scan showed a hemispheric
stroke in the left carotid artery territory. The patient under-
went a rehab programme with a modest functional recovery
andwas discharged fromhospital 50 days after the procedure.
Three patients presented postoperative complications. One
patient had an acute onset of renal failure 3 days after the
procedure. He had a previously well-known “shaggy” distal
thoracic aorta and underwent a postoperative angio-CT scan
control, showing multiple distal emboli in the territory of bothF L1 L2 L3 LZ
110 1 6 9 16
130 4 7 9 20
135 2 6 7 15
90 6 6 4 16
120 1 5 13 19
150 5 7 14 26
90 1 6 14 21
115 9 5 5 19
150 8 6.5 4.5 19
135 1 6.5 7 14.5
140 1 6 4 11
140 6 7 6 19
150 1 7 11 19
120 4 6 3 13
80 4 7 9 20
145 8 7 5 20
115 4 6 6 16
110 7 5.5 17 24
75 9 6.5 8 17
160 6 6 10 22
120 6 6 2 14
130 8 6 6 20
nd lengths are reported in mm.
Table 3. Operative components and follow-up (F/U) complications.
Pt. Main body Stent type Endoleak F/U time
(months)
Complications F/U
1 32 Zenith Flex 6  30 S.M.A.R.T. None 35
2 32 Zenith Flex 6  30 Lifestent None 31 Post-op. multiple renal and splenic emboli, acute
kidney injury.
3 26 Zenith AUI 6  40 Lifestent II 29
4 28 Zenith Flex 6  40 Everﬂex None 28
5 28 Zenith Flex 6  40 Lifestent None 28
6 28 Zenith Flex 6  40 Lifestent None 26
7 32 Zenith LP 6  40 Lifestent None 24 Post-op. left hemispheric stroke
8 24 Zenith LP 6  30 Absolute None 20
9 32 Zenith LP 7  30 Astron None 19
10 28 Zenith LP 7  30 Lifestent II 18 EL disappeared at 3 months
11 26 Zenith LP 6  30 Lifestent II 18
12 24 Zenith LP 5  30 Epic None 18 Post-op. gluteus rhabdomyolysis (IIA occlusion),
acute renal failure.
13 24 Zenith LP 7  40 Lifestent Ia 18 EL disappeared at 3 months
14 28 Zenith AUI 7  40 Lifestent None 18
15 36 Zenith Flex 7  40 Absolute None 18
16 24 Zenith LP 7  20 Epic None 16
17 26 Zenith LP 6  40 Lifestent None 13 Post-op. death (4 hours) for decompensated
heart failure
18 28 Zenith LP 6  60 Lifestent None 13
19 28 Zenith LP 7  60 Lifestent II 13
20 32 Zenith LP 7  30 Absolute None 10
21 25 Endurant 7  40 Astron None 9 Post-op. (9 days) left endograft leg thrombosis/
thrombectomy þ stenting
22 22 Powerlink 6  40 Lifestent None 7
Main body ¼ endograft main body diameter (mm) and type; stent type: diameter  length (mm) and commercial name; IIA ¼ internal iliac
artery.
128 E. Ducasse et al.renal and the splenic arteries with normal patency of themain
branches as also indicated in the ﬁnal procedural angiography.
The patient was transferred to the nephrology division
showing a signiﬁcant improvement in renal function without
requiring dialysis and with a moderate stable increase (>20%)
in creatinine values (w2.5 mg/dL) during the follow-up and
changed from Chronic Kidney Disease (CKD) stage 2 to stage
3b. Another patient had a progressive pain in the right gluteus
starting the 1st postoperative day, which progressed into
rhabdomyolysis and acute renal failure. The patient had a
planned occlusion (coils and plug embolisation) of the right
internal iliac artery because of a concomitant common iliac
aneurysm.Thepatientwas also treated conservativelywithout
requiring dialysis with serum creatinine returning almost back
to preoperative values during the follow-up, switching to CKD
stage 3a to 3b, with a creatinine increase <20%. He suffered
from a moderate right buttock claudication. The last patient
presented an iliac leg occlusion at the CT control before
discharge without symptoms and with an otherwise un-
eventful postoperative stay. The occlusion was caused by a
kinking between the common and the external iliac artery
following endograft positioning and was successfully treated
by thrombectomy and uncovered stent delivery from the
endograft leg to the ﬁrst portion of the external iliac artery.
Follow-up CT and Duplex scans showed patency of all
renal arteries without any sign of chimney stent or RA
stenosis (Fig. 2) at the median follow-up of 18 months
(range 7e35). No aneurysm has enlarged during the follow-up with a median sac regression for the entire cohort of
9 mm at latest follow-up. With the exception of the two
patients presenting the renal function complications
described above, no changes were observed of preopera-
tive CKD stages and serum creatinine values, post-
operatively and during the follow-up.
DISCUSSION
Since the ﬁrst description of the GC technique as a bailout
procedure6 in 2003, this “off-label” technique has been
improved and expanded by different authors8e11 to restore
ﬂow in aortic branches accidentally or intentionally covered
and to obtain an adequate sealing during TEVAR in the aortic
arch, for patients with JRAAs and in urgent cases when off-
the-shelf devices need to be employed. Many studies have
been published on CG technique with relatively good peri-
operative and short-term results as described by Moulakakis
et al.11 in the metanalysis evaluating the results of 15 recent
reports on the CG technique for JRAA.
The 30-day mortality of our series was 4.5%, similar to
the mortality (4.3%) in the reported metanalysis.11 The
mortality for JRAA in our study is low considering 82% of
the patient cohort were deemed class III and IV American
Society of Anesthesiologists (ASA) and 76% presented se-
vere cardiac disease. The deceased patient in our series
presented a very poor cardiac status (ejection fraction <30).
Stroke complications are reported during CG-EVAR and
could represent a limitation also in theOCh graft technique as
Figure 2. Two (a and b) CT 3-D reconstructions of OCh-EVARs
showing the endovascular grafts with proximal open struts and
the OCh grafts into the left renal arteries.
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access. In the same metanalysis,11 Moulakakis described
ischaemic stroke in 3.2% of patients. One patient in our series
presented a perioperative ischaemic stroke in the territory of
the left carotid artery. Ischaemic stroke in the left carotid
cerebral area is unexpected during left brachial access and
could also be explained by wire manipulation across the
aortic arch from distal femoral accesses.
Additional 30-day complications were related to complex
distal accesses (iliac artery tortuosity and aneurysm) in two
patients and to a diseased proximal aorta in the other. In
this last patient multiorgan embolisation (spleen and kid-
neys) could be explained by stiff guidewires and catheter
manipulation coming from proximal as well as distal ac-
cesses across the “shaggy” thoracic aorta. The two observed
postoperative acute renal failures are to be ascribed to such
complications and not to chimney graft delivery.
Aneurysm exclusion and patent OCh graft were achieved
in all patients. The median time of the procedure (105 mi-
nutes), estimated blood loss (55 mL), contrast medium
(65 mL), and X-ray time exposure (23 minutes) demonstrate
that OCh-EVAR is a straightforward technique for complex
aortic aneurysm disease.
Patients included in the present study represent a sub-
population of patients presenting with JRAA. Indication to
OCh-EVAR requires a discrepant origin of the two RAs in
JRAA. In our experience, this anatomical condition occurredin 20% (22/106) of all JRAAs undergoing EVAR during the
same period of time.
Because of the position of the aorta, the inferior vena
cava, and the kidneys in the body, the origin of the two RAs
at different cross-sectional levels from the aorta is a com-
mon anatomical condition.12 In one study the right and left
renal arteries were reported to be at the same level in only
30% of cases, whereas the right was higher in 47% and the
left was higher in about 23% of cases.13 There were no
reported sex- (gender) or race-related differences.
Major limitations of the present study are the low
number of treated patients and the relatively short follow-
up time. However, among published series on CH-EVAR, the
present series is one of the largest and with the longest
follow-up.11 Another clear limitation of the present study is
that this is neither a randomised, nor even a controlled trial
with any comparisons, and results should be interpreted
cautiously. The small number of expected patients (high
physiological risk in selected JRAA anatomies) would have
made any statistically signiﬁcant conclusion difﬁcult to
reach with any possible control group.
An alternative endovascular approach to JRAA in our
series was the F-EVAR. A single-fenestration conﬁguration is
rarely used in F-EVAR. According to manufacturer
instructions for ordering (Zenith Fenestrated, Cook),
F-endograft engineering requires a distance 15 mm be-
tween a small fenestration and the proximal edge of the
graft. Such condition (distance between the two RAs
15 mm) was present only in one patient of our series
(Table 2). Therefore, in 95.5% of our series, two fenestra-
tions and most probably a scallop would have been
requested to manufacture a fenestrated endograft. More-
over, the tortuosity of the aorta in our series (median F
angle: 125) would have potentially made F-EVAR more
difﬁcult than OCh-EVAR. In F-EVAR, one or two fenestra-
tions with or without a scallop in the partially opened F-
endograft should be aligned with the corresponding target
vessels along the angled neck, whereas in OCh-EVAR, one
renal artery is targeted before the endograft is positioned
into the aorta. Therefore, besides the time required for the
customisation, complexity of the procedure, X-ray exposure,
and costs would have undoubtedly increased with F-EVAR.
Covered stent grafts are usually employed in CG-EVAR.14,15
However, uncovered CG have been used and described by
other authors. The ideal characteristics of the renal artery
stent (covered vs. uncovered, self-expanding vs. balloon-
expandable) for use in the CG procedure have not yet been
clariﬁed. Hiramoto et al.16 successfully used uncovered
stents, not only as bailout techniques to rescue a renal artery
but also in planned procedures to increase the proximal
landing zone in selected cases (eight patients). The authors
also performed CG-EVAR, using a single uncovered graft for
one low-lying renal artery. We have systematically used the
OCh-technique when the previously described anatomical
criteria in JRAA were encountered, offering this procedure to
22 consecutive patients. We agree with Hiramoto et al. that
the covered nature of the stent does not confer any advan-
tage in renal patency nor any protection against a type I
Figure 3. CT scan cross-section (6-month follow-up) at the proximal
level of OCh graft and endograft main body running parallel,
showing the “physiological” gutter (white arrows) between the
two components. The gutter ends at the bottom part of the OCh
graft, without creating any type Ia endoleak.
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nal”neck is present. In our opinion, an uncovered stent allows
a higher renal blood ﬂow through the “physiological” gutter
(Fig. 3) and open stent struts possibly conferring an advan-
tage in the long-term patency. Unlike Hiramoto et al., our
preference is for the new generation of self-expanding stents
because of their ﬂexibility, stability during release (anti-
jumping mechanisms), and the reduced size of the delivery
system (up to 4F in the Astron18, Biotronic).
When the two RAs origin at the same level in JRAA, we
prefer a F-technique or GG-strategy using covered stent
grafts. Two or more chimney grafts displace the endograft
fabric further from the aortic wall increasing the risk of type
Ia endoleak and therefore a longer sealing zone may be
required and uncovered stents may not be adequate.
In our series, a small type I endoleak was observed only
in one patient (4.5%) and disappeared at the 3-month CT
scan control, without any evidence of new endoleaks at the
median follow-up of 18 months.
Conclusions
The results of the present study show that the OCh-EVAR is a
straightforward technique that can be employed in selected
cases of JRAA with discrepant renal arteries. In such
anatomical conditions, OCh-EVAR has the advantages of
reducing the complexity, manufacturing time, and costs of F-
EVAR. Compared with covered stents, SES requires a smaller
and more ﬂexible delivery system, potentially reducing
complications from left brachial access. The median 18-
month follow-up results of this technique are very encour-
aging without any type I and III endoleaks, CG stenosis or
renal function deterioration, although longer-term follow-up
is awaited to establish the durability of this approach.
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